Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 3
2000 2
2001 2
2002 3
2003 4
2005 6
2006 3
2007 3
2008 3
2009 1
2010 7
2011 3
2012 3
2013 4
2014 4
2015 10
2016 4
2017 5
2018 3
2019 6
2020 5
2021 7
2022 5
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma.
Zhang P, Rashidi A, Zhao J, Silvers C, Wang H, Castro B, Ellingwood A, Han Y, Lopez-Rosas A, Zannikou M, Dmello C, Levine R, Xiao T, Cordero A, Sonabend AM, Balyasnikova IV, Lee-Chang C, Miska J, Lesniak MS. Zhang P, et al. Among authors: balyasnikova iv. Nat Commun. 2023 Mar 23;14(1):1610. doi: 10.1038/s41467-023-37328-9. Nat Commun. 2023. PMID: 36959214 Free PMC article.
New Approaches to Glioblastoma.
Khasraw M, Fujita Y, Lee-Chang C, Balyasnikova IV, Najem H, Heimberger AB. Khasraw M, et al. Among authors: balyasnikova iv. Annu Rev Med. 2022 Jan 27;73:279-292. doi: 10.1146/annurev-med-042420-102102. Epub 2021 Oct 19. Annu Rev Med. 2022. PMID: 34665646 Free PMC article. Review.
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.
Fares J, Ahmed AU, Ulasov IV, Sonabend AM, Miska J, Lee-Chang C, Balyasnikova IV, Chandler JP, Portnow J, Tate MC, Kumthekar P, Lukas RV, Grimm SA, Adams AK, Hébert CD, Strong TV, Amidei C, Arrieta VA, Zannikou M, Horbinski C, Zhang H, Burdett KB, Curiel DT, Sachdev S, Aboody KS, Stupp R, Lesniak MS. Fares J, et al. Among authors: balyasnikova iv. Lancet Oncol. 2021 Aug;22(8):1103-1114. doi: 10.1016/S1470-2045(21)00245-X. Epub 2021 Jun 29. Lancet Oncol. 2021. PMID: 34214495 Free PMC article. Clinical Trial.
Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.
Fares J, Petrosyan E, Kanojia D, Dmello C, Cordero A, Duffy JT, Yeeravalli R, Sahani MH, Zhang P, Rashidi A, Arrieta VA, Ulasov I, Ahmed AU, Miska J, Balyasnikova IV, James CD, Sonabend AM, Heimberger AB, Lesniak MS. Fares J, et al. Among authors: balyasnikova iv. J Clin Invest. 2023 Dec 15;133(24):e161142. doi: 10.1172/JCI161142. J Clin Invest. 2023. PMID: 37847564 Free PMC article.
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM.
Zannikou M, Duffy JT, Levine RN, Seblani M, Liu Q, Presser A, Arrieta VA, Chen CJ, Sonabend AM, Horbinski CM, Lee-Chang C, Miska J, Lesniak MS, Gottschalk S, Balyasnikova IV. Zannikou M, et al. Among authors: balyasnikova iv. J Immunother Cancer. 2023 Feb;11(2):e006239. doi: 10.1136/jitc-2022-006239. J Immunother Cancer. 2023. PMID: 36759014 Free PMC article.
X-ray Activated Nanoplatforms for Deep Tissue Photodynamic Therapy.
Souris JS, Leoni L, Zhang HJ, Pan A, Tanios E, Tsai HM, Balyasnikova IV, Bissonnette M, Chen CT. Souris JS, et al. Among authors: balyasnikova iv. Nanomaterials (Basel). 2023 Feb 9;13(4):673. doi: 10.3390/nano13040673. Nanomaterials (Basel). 2023. PMID: 36839041 Free PMC article. Review.
100 results